Skip to content

Advertisement

  • Research
  • Open Access

Determinates of depressive disorder among adult patients with cardiovascular disease at outpatient cardiac clinic Jimma University Teaching Hospital, South West Ethiopia: cross-sectional study

  • 1,
  • 2,
  • 3 and
  • 3Email author
International Journal of Mental Health Systems201913:13

https://doi.org/10.1186/s13033-019-0269-8

  • Received: 27 November 2018
  • Accepted: 22 February 2019
  • Published:

Abstract

Background

Depression and heart disease are an important public-health problem. Depression is one of the most prevalent and disabling psychiatric disorders with more than three times increased risk among patients with cardiovascular disorders.

Objective

To identify the prevalence and associated factors of depressive disorder among adult patients with cardiovascular disease.

Methods

Institution based cross-sectional study design was used to conduct this study on 293 study participants attending an outpatient cardiac clinic at Jimma University Teaching Hospital. All eligible patients were recruited into the study consecutively. Depression was assessed using patient health questionnaire-9. The patient health questionnaire-9 had a total score of 27, from which 0–4: no/minimal depression, 5–9: mild depression, 10–14: moderately depression, 15–19: moderately severe depression and 20–27 severe depression. The data was feed into Epi-data version 3.1 and lastly exported to SPSS version 21 for analysis. Bivariate analysis was used to analyze the statistical association of covariates of interest with depressive disorder among patients with cardiovascular disease. Then, logistic regression analysis was used as a final model to control confounders. The strength of association was measured by a 95% confidence interval.

Results

A total of 293 adult patients diagnosed with the cardiovascular disease were included in the study with 97% (n = 284) of response rate, 47.2% (n = 134) males and 52.8% (n = 150) females, making female to a male ratio around 1.1:1. The prevalence of depression was 52.8% (n = 150/284). Out of the subjects with depression 52.67% (n = 79), 36.0% (n = 54) and 11.33% (n = 17) were mild, moderate and severe depression, respectively. Variables such as employed, unemployed, physical activity, current cigarette user and poor social support were independently associated with depression in the final model.

Conclusions

In this study, depression was found to be highly prevalent psychiatric comorbidity in adult cardiovascular disease patients.

Keywords

  • Depression
  • Cardiovascular disease
  • Ethiopia
  • Determinants
  • Patient health questionnaire-9

Background

Non-communicable diseases (NCD) currently account 60% of all deaths and 48% of the disability-adjusted life years (DALYs) worldwide, 40% for communicable diseases. In 2008, four out of five NCD deaths occurred in low- and middle-income countries [1]. Mental disorders are a major contributor to the burden of disease in all regions of the world [2]. Mental health conditions are the leading cause of DALYs worldwide and account for 37% of years of life lost (YLL) from NCDs [1].

According to the World Health Organization (WHO) report in 2011 unipolar depressive disorder is the third leading cause of disease burden worldwide. Mental disorders account for 25.3% and 33.5% of all years lived with a disability in low- and middle-income countries (LAMICs), respectively [3]. Mental illness is both a direct cause of mortality and a major risk factor for adverse health outcomes [4].

Depression is a substantial contributor to the global burden of disease. It affects people in all communities worldwide. In 2012, the WHO reported that depression is estimated to affect 350 million peoples [5]. Depression is a common mental disorder that has a clinical feature of depressed mood, loss of interest, reduced energy, feelings of guilt or low self-esteem, disturbance of sleep/appetite, and poor concentration, severe enough to cause severe impairment in important role function. At its worst, depression leads to suicide and is responsible for 1 million deaths due to suicide every year, which translates to 3000 suicide deaths every day [5].

World Health O report shows that 17.3 million people died from CVDs, contributing to 30% of all global deaths and this represents 50% of all death from NCD. In the same year, CVDs were the number one cause of death and deaths from these disorders in LAMIC constituted 80% [6, 7]. At the same time, it is estimated that about 19 million deaths occur annually from cardiovascular causes in lower-income countries [1, 6]. Mental health and cardiovascular diseases account for almost 70% of global economic losses [1].

The reported prevalence of major depression in patients with CAD is around 20%, the prevalence of depression is among patient with CHD is very high (31–34%) and is about three times more compared to that in the general population. Moreover, depression has been found to be a risk factor for the development of CAD and worsens its outcome when depression co-exists with established CAD [1921]. One-fifth of the patients with CHD attending outpatients and one-third of patients with congestive heart failure (CHF) have co-existing depression.

Depression in patients with CHD and CHF, however, is not recognized or not properly treated most of the time [8].

Quality of life of patients and their significant others are seriously affected by debilitating physical health, psychological distress, and diminished family role [9]. In patients undergoing coronary artery bypass graft (CABG), depression has been associated with longer hospitalization, poorer functional outcomes, more preoperative complications, higher rates of mortality and more symptomatic before and also after surgery [10, 11].

Effects of untreated depression that include: increased risk of a coronary event, decreased feelings of wellbeing and quality of life (QOL), decreased medication compliance and decreased risk factor modification. Can seriously increase the risks of further cardiac morbidity or mortality. Despite this knowledge; Physicians usually under-detect depression among cardiac patients; moreover, some of the cardiovascular drugs such as beta blockers may worsen the overall depressive symptoms [12, 13].

Factors associated with depression, most studies have found that younger patients and women were more likely to have the disorder in the context of CVD [16]. Poor social support, prior ACS, and in some cases, comorbid diabetes may also increase depression risk [1416].

Many studies implicate depression among CAD patients to have the association with female sex, younger age, living situation, prior ACS, comorbid diabetes, HF severity class, low educational attainment, use of beta blockers, being housewives, unemployment status [14, 1721]. Positive family history of depression, smoking, history of CHD/MI, social isolation/social support, NYHA CLASS classification system based on clinical severity and prognosis, antihypertensive medication [22, 23]. People with depression are 25 to 40% more likely to die from heart disease than people without depression [24].

Furthermore, several candidate biological and behavioral factors believed to be mechanisms through which depression could lead to cardiac events have been identified. Such as tricyclic antidepressants toxicity associated with cardiac risk factors. Potential behavior related mechanisms comprise dietary factors, sedentary lifestyle with lack of exercise, non-adherence to cardiac prevention and treatment regimens, lack of optimal social support, unhealthy lifestyles such as smoking, alcoholism and reduced functional capacity [8, 25].

Therefore, the fact that depression is a predictor of cardiac events among patients with CVD is has gained universal consensus although such information is lacking from countries such as Ethiopia. Furthermore, it was a well-known fact that comorbid depression increases negative events such as progression to arteriosclerosis, increased health care utilization and increased hospital readmissions before or after a cardiac event.

In spite of, evidence has suggested that depression can aggravate the course of multiple cardiovascular conditions, detection of depression in cardiac patient remains low. According to the principal investigator’s knowledge, there is no study conducted in Ethiopia and the extent of the problem is not yet known. A better understanding of the extent of depression and associated factors is significant. This research will narrow this huge gap and will serve as a baseline for further researches to be undertaken on the subject matter.

Methods and materials

Study setting and period

The study was conducted in Jimma University Teaching Hospital (JUTH) outpatient cardiac clinic from October to November 2014. It has been running a public health care institution under the ministry of health by different names at a different time. Geographically, it is located in Jimma town 352 km south west of Addis Ababa. It provides service for at least 15 million populations residing in South-West Ethiopia. The cardiac clinic is one of the follow-up clinics giving service for a patient with chronic CVDs among other clinics that give service for patients with other chronic NCDs [26].

Participants

The study participants were all adult patients who had CVD age 18 years and above who came for follow-up at JUTH cardiac clinic during the study period. A total of 293 adult patients who had CVD were involved in the study. This study exclude, individual who seriously ill and were not able to give information, had a severe neuropsychiatric condition or language deficit that would preclude informed consent or valid assessment was excluded.

Measurements

The dependent variable was depression. The independent variables include socio-demographic characteristics such as age, sex, marital status, educational status, place of residence, income, empowerment, psychosocial, medication, clinical-related, behavioral and lifestyle factors.

Data collection procedures and instruments

Data were collected using interview-administered questionnaires. Questionnaires were abstracted and adapted from different literature sources and modified according to the local context. The questionnaire prepared by the English language, translate to Afan Oromo and Amharic language by the language department who is a native speaker for oromifa language and back translation also made. Depression was measured using patient health questionnaire nine (PHQ-9) which is a validated instrument in Ethiopia [27]. The PHQ-9 has a total score of 27, from which 0–4: no/minimal depression, 5–9: mild depression, 10–14: moderately depression, 15–19: moderately severe depression and 20–27 severe depression. Morisky medical adherence scale-8 (MMAS-8) was used to assess medication adherence which is a validated tool in Ethiopia to screening and monitoring in clinical practice to identify and monitor high-risk non-adherent patients [28].

Oslo 3-items social support scale (OSS-3) was used to measure the strength of social support [29]. Pretest of the questionnaire was carried out on 5% of respondents; whose socio-demographic factors are the same with those actual study participants; from the cardiac clinic in Jimma University Teaching Hospital (JUTH) those individuals not included in the main study differentiated by making a mark on their chart.

Data processing, analysis, interpretation, and presentation

The quantitative data were entered into the computer by using Epi-data version 3.1 and lastly exported to SPSS version 21 for analysis. Bivariate analysis and multiple logistic regressions were used. Finally, variables had a P-value of less than .25 on binary logistic regression were entered into multivariable logistic regression. The strength of association was measured by 95% confidence interval and Then P-value < .05 considered as significantly associated variables with depression in the final model. The result was presented by frequency tables, graphs and discussed with previous study findings.

Ethical consideration

The ethical approval of the study was obtained from the Ethical Review Board of Jimma University, college of public health and Medical Sciences. Oral consent was obtained from the study participants. Patient those found to be severally depressed and suicidal risk appropriate intervention was done according to PHQ-9 score.

Results

Socio-demographic characteristics

A total of 293 adult patients diagnosed with CVD were included in the study with a response rate of 97% (n = 284). Out of the total respondents 47.2% (n = 134) males and 52.8% (n = 150) females with male-to-female ratio of 1.1:1. The age of the respondents ranged from 18 to 90 with a mean (SD) of 50.3 (17.13) years.

Nearly to two-third of (64.4%) patients came from the rural area and nearly three-fourths of the respondents were married (76.0%). About one-half of the total participants were illiterate (53.2%) (n = 151). Regarding the occupation status, more than one half of the total of the respondents were farmers, 50.7% (n = 144). Unemployed and housewives constituted 18% (n = 144) and 8.8% (n = 25) respectively. About 26.1% (n = 74) of the study participants claimed to earn an annual average income of 10,800 birrs (Table 1).
Table 1

Socio-demographic characteristics of the respondents in Jimma University Teaching Hospital cardiac clinic, 2014–2015 (n = 284)

Characteristics

Non depressed (PHQ-9 < 5)

N (%)

Depressed (PHQ-9 ≥ 5)

N (%)

Total (%)

Sex

 Male

60 (44.8)

74 (49.3)

134 (47.2)

 Female

74 (55.2)

76 (50.7)

150 (52.8)

Age

 18–26

17 (12.7)

17 (11.3)

34 (12.0)

 27–35

15 (11.2)

21 (14.0)

36 (12.7)

 36–44

20 (14.9)

13 (8.7)

33 (11.6)

 45–53

22 (16.4)

25 (16.7)

47 (16.5)

 –62 ref

28 (20.9)

26 (17.3)

54 (19.0)

 63–71

22 (16.4)

28 (18.7)

50 (17.6)

 ≥ 72

10 (7.5)

20 (13.3)

30 (11.2)

Marital status

 Single

20 (14.9)

13 (8.7)

33 (11.6)

 Married

105 (78.4)

111 (74.0)

216 (76.0)

 Divorced/separate

4 (3.0)

10 (6.7)

14 (5.0)

 Widowed

5 (3.7)

16 (10.7)

21 (7.4)

Educational status

 Illiterate

67 (5.0)

84 (56.0)

151 (53.2)

 Able to read and write only

20 (14.9)

36 (24.0)

56 (19.7)

 Primary (1–8)

28 (20.9)

19 (12.7)

47 (16.5)

 Secondary (9–12)

14 (10.4)

7 (4.7)

21 (7.4)

 Tertiary (+12)

5 (3.7)

4 (2.7)

9 (3.2)

Occupational status

 Unemployed

16 (11.9)

35 (23.3)

51 (18.0)

 Employed

12 (9.0)

4 (2.7)

16 (5.6)

 Farmer

70 (52.2)

74 (49.3)

144 (50.7)

 Merchant

9 (6.7)

10 (6.7)

19 (6.7)

 Retired

7 (5.2)

5 (3.3)

12 (4.2)

 Housewife

11 (8.2)

14 (9.3)

25 (8.8)

 Other

9 (6.7)

8 (5.3)

17 (6.0)

Residence

 Rural areas

80 (59.7)

103 (68.7)

183 (64.4)

 Urban areas

54 (40.3)

47 (31.3)

101 (35.6)

Average annual income

 0–999

33 (24.6)

37 (24.7)

70 (24.6)

 1000–3599

32 (23.9)

37 (24.7)

69 (24.3)

 3600–10,799

28 (20.9)

43 (28.7)

71 (25.0)

 ≥ 10,800

41 (30.6)

33 (22.0)

74 (26.1)

Other employment status—student, daily labor and house servants

Psychosocial and behavioral factors

The majority (90.5%) of respondents were living with their family and 6.3% (n = 18) were living alone. Only 24.4% (n = 69) reported having good social support whereas 35.2% (n = 100) claimed to have poor social support. Those who reported having almost satisfactory or moderate social support constituted 40.5% (n = 115). About half of respondent (48.9%) do not do moderate to vigorous activities for 30 min or more, at least 4 days in a week. Respondents who used that in their lifetime were 26.8% (n = 76) and 8.8% (n = 25) were current use (Table 2).
Table 2

Psychosocial and behavioral related characteristics of the respondents in Jimma University Teaching Hospital cardiac clinic, 2014–2015 (n = 284)

Characteristics

Non depressed

N (%)

Depressed

N (%)

Total

N (%)

Living condition

 Alone

6 (4.5)

12 (8.0)

18 (6.3)

 With family

121 (90.3)

136 (90.7)

257 (90.5)

 Othera

7 (5.2)

2 (1.3)

9 (3.2)

Oslo 3-items social support scale

 Poor support

38 (28.4)

62 (41.3)

100 (35.2)

 Moderate support

62 (46.3)

53 (35.3)

115 (40.5)

 Strong support

34 (25.4)

35 (23.3)

69 (24.3)

Physical activity

 Yes

79 (59.0)

66 (44.0)

145 (51.1)

 No

55 (41.0)

84 (56.0)

139 (48.9)

Life time used substances

 Cigarette

  Yes

9 (6.7)

17 (11.3)

26 (9.2)

  No

125 (93.3)

133 (88.7)

258 (90.8)

 Alcohol

  Yes

19 (14.2)

15 (10.0)

34 (12.0)

  No

115 (85.8)

135 (90.0)

250 (88.0)

 Khat

  Yes

33 (24.6)

43 (28.7)

76 (26.8)

  No

101 (75.4)

107 (71.3)

208 (73.2)

 Cannabis

  Yes

4 (3.0)

6 (4.0)

10 (3.5)

  No

130 (97.0)

144 (96.0)

274 (96.5)

Current used substances

 Cigarette

  Yes

3 (2.2)

11 (7.3)

14 (4.9)

  No

131 (97.8)

139 (92.7)

270 (95.1)

 Alcohol

  Yes

7 (5.2)

11 (7.3)

18 (6.3)

  No

127 (94.8)

139 (92.7)

266 (93.7)

 Khat

  Yes

14 (10.4)

11 (7.3)

25 (8.8)

  No

120 (89.6)

139 (92.7)

259 (91.2)

 Cannabis

  Yes

2 (1.5)

3 (2.0)

5 (1.8)

  No

132 (98.5)

147 (98.0)

279 (98.2)

Living condition othera With relative/friends/homeless

Clinical characteristics and medication related factors

Medication related factors

The most prescribed drugs were diuretics in 75.0% (n = 213); angiotensin-converting enzyme inhibitors in 55.3% (n = 157) and beta-blockers in 45.2% (n = 137). The rate of depression was higher at 77.3% (n = 116) among participants who were taking diuretics. The majority of participants, 32.0% (n = 91) were ≤ 1 year of duration of treatment. The rate of depression is higher among those whose duration of treatment for CVD was greater than or equal to 5 years 30.7% (n = 46). Nearly three-fourth of participants (n = 206) were adherence to CVD medication (Table 3).
Table 3

Depression relation to medication taken by CVD patients, JUTH cardiac clinic, 2014–2015 (n = 284)

Characteristics

Total

N (%)

Nondepressed

N (%)

Depressed

N (%)

Medication

 Digoxin

62 (21.8)

33 (24.6)

29 (19.3)

 Diuretic

213 (75.0)

97 (72.4)

116 (77.3)

 Beta blocker

137 (45.2)

72 (53.7)

65 (43.3)

 Angiotensin-converting enzyme inhibitor

157 (55.3)

72 (53.7)

85 (56.7)

 Calcium channel blocker

24 (8.5)

9 (6.7)

15 (10.0)

 Anticoagulant

149 (52.5)

70 (52.2)

79 (52.7)

 Statine (lipid lowering agents)

22 (7.7)

11 (8.2)

11 (7.3)

 Penicillin

23 (8.1)

10 (7.5)

13 (8.7)

 Other?

17 (6.0)

8 (6.0

9 (6.0)

Duration of treatment (year)

 ≤ 1

91 (32.0)

50 (37.3)

41 (27.3)

 1–2

51 (18.0)

24 (17.9)

27 (18.0)

 2–3

29 (10.2)

12 (9.0)

17 (11.3)

 3–4

30 (10.6)

11 (8.2)

19 (12.7)

 ≥ 5

83 (29.2)

37 (27.6)

46 (30.7)

Medication adherence

 Non adherent

78 (27.5)

45 (30.0)

33 (24.6)

 Adherent

206 (72.5)

105 (70.0)

101 (75.4)

Other medications—vasodilator, broncho-dilator, steroid, PTU, insulin, metformine, daonil, valsartan

Clinical related factors

The majority of participants were diagnosed with Hypertensive heart disease (HHD) constituting 35.9% (n = 102). Cases with CHD were found in 26.4% (n = 75) whereas patients with Valvular heart disease (VHD) were found in 12.3% (n = 35). The highest rate of depression was found among HHD 36.0% (n = 54) and the lowest in other diagnostic groups of CVD (Corpulmonary, acute rheumatic fever, congenital heart disease, pericarditis and CHF due to thyrotoxicosis) classification 6.0% (n = 9). Among depressed 30.0% (n = 45) were the age of onset of CVD above 60 years. Close to one-third (30%) of the patients have been ill with CVD for the duration of 1–3 years.

Majority of participants 87.3% (n = 248) had no family history of mental illness. From those who had a family history of mental illness (55.6%; n = 20/36) were more depressed as compared to those no history of depression (44.4%; n = 16/36). Two hundred seventy (95.1%) of participants had no comorbid diabetes mellitus. Among those who had comorbid diabetes mellitus, most had depressed mood (64.3%; n = 9/14) as compared to that non-comorbid diabetes mellitus (35.7%; n = 5/14) with depression. Majority of participants who had comorbid diabetes mellitus 72.7% (n = 8) had onset ≤ 3 years after CVD illness. They had more depression (71.4%) as compared to those who had > 3 years of duration of comorbid DM after the onset of CVD illness.

Participants those who had comorbid hypertension constituted 45.1% (n = 128). Among CVD patients with comorbid hypertension, depression prevalence was 46.0% (n = 69). Among those who had comorbid hypertension their duration of onset ≤ 3 years, after CVD illness 64.0% (n = 33) were more depressed as compared to duration > 3 years of comorbid hypertension. Majority of the participants 60.9% (n = 173) with the previous history of hospitalization had more prevalence rate of depression (64.0%), as compared to previously none hospitalized for CVD patients (Table 4).
Table 4

Distribution of respondents by clinical related factors in JUTH cardiac clinic, 2014–2015 (n = 284)

Characteristics

Total

N (%)

No depressed

N %

Depressed

N (%)

Diagnosis type of CVD illness

 Hypertensive heart diseases

102 (35.9)

48 (35.8)

54 (36.0)

 Ischemic heart disease

75 (26.4)

37 (27.6)

38 (25.3)

 Valvular heart disease

35 (12.3)

11 (8.2)

24 (16.0)

 Rheumatic heart disease

26 (9.2)

14 (10.4)

12 (8.0)

 Cardiomyopathy

29 (10.2)

16 (11.9)

13 (8.7)

 Other

17 (5.0)

8 (6.0)

9 (6.0)

Duration of CVD illness (year)

 ≤ 1

68 (23.9)

36 (26.9)

32 (21.3)

 1–3

78 (27.5)

37 (27.6)

41 (27.3)

 3–5

58 (20.4)

26 (19.4)

32 (21.3)

 5–7

35 (12.3)

15 (11.2)

20 (13.3)

 > 7

45 (15.8)

20 (14.9)

25 (16.7)

Family history of mental illness

 Yes

36 (12.7)

16 (11.9)

20 (13.3)

 No

248 (87.3)

118 (88.1)

130 (86.7)

Comorbid diabetes mellitus

 Yes

14 (4.9)

5 (3.7)

9 (6.0)

 No

270 (95.1)

129 (96.3)

141 (94.0)

Duration of DM after onset of CVD illness (year)

 ≤ 3

8 (72.7)

3 (75.0)

5 (71.4)

 > 3

3 (27.3)

1 (25.0)

2 (28.6)

Comorbid hypertension

 Yes

128 (45.1)

59 (44.0)

69 (46.0)

 No

156 (54.9)

75 (56.0)

81 (54.0)

Duration of HTN after onset of CVD illness (years)

 ≤ 3

60 (63.8)

27 (62.8)

33 (64.7)

 > 3

34 (36.2)

16 (37.2)

18 (35.3)

NYHA class

 I

16 (7.1)

6 (5.8)

10 (8.3)

 II

116 (51.8)

54 (52.4)

62 (51.2)

 III

57 (25.4)

27 (26.2)

30 (24.8)

 IV

35 (15.6)

16 (15.5)

19 (15.7)

Lipid profile level

 Total cholesterol (mg/dl)

  < 200

18 (78.3)

7 (63.6)

11 (91.7)

  ≥ 200

5 (21.7)

4 (36.4)

1 (8.3)

 Low density lipoprotein (mg/dl)

  < 40

9 (36.0)

4 (36.4)

5 (35.7)

  ≥ 40

16 (64.0)

7 (63.6)

9 (64.3)

 Triglycerides (mg/dl)

  < 150

10 (45.5)

4 (40.0)

6 (50.0)

  ≥ 150

12 (54.5)

6 (60.0)

6 (50.0)

Other diagnosis—corpulmonary, acute rheumatic fever, congenital heart disease, pericarditis, CHF due to thyrotoxicosis

New York Heart Association classification among CVD patients and its association with depression

One-half of the participants (51.8%) belonged to NYHA-class II as documented in the secondary data. The prevalence rate of depression in this group was 51.2% (n = 62). This is more than in each of the remaining groups (Table 4).

Lipid profile among CVD patients and its association to depression

Cholesterol was investigated and found that patients with a total cholesterol level of < 200 mg/dl constituted in 78% and that they were more depressed 91.7% as to compared with those having total cholesterol level > 200 mg/dl. Those having lipoprotein level > 40 mg/dl were 64% and they were the ones more depressed as compared to those whose LDL level of was < 40 mg/dl. Similarly CVD patients with triglycerides level of < 150 mg/dl were compared with having triglycerides level > 150 mg/dl but there was no statistically significant difference in the level of depression (Table 4).

Prevalence of depression

Two hundred eighty-four of participants completed the interview of PHQ-9 questions at baseline. The prevalence of depression was 52.8% (n = 150) (Fig. 1).
Fig. 1
Fig. 1

Prevalence of depression among CVD patients in JUTH cardiac clinic, 2014–2015 (n = 284). PHQ-9 classification of Depression in Jimma University Teaching Hospital cardiac clinic, 2014/15 (n = 284)

Out of the subjects with depression 52.67% (n = 79), 36.0% (n = 54), 10.0% (n = 15), 1.33% (n = 2) mild, moderate, moderately severe, and severe depression, respectively had depressive symptoms (Fig. 2).
Fig. 2
Fig. 2

Depression PHQ-9 classification of respondents in Jimma University Teaching Hospital cardiac clinic, 2014/15 (n = 284)

Factors associated with depression in bivariate analysis among adult CVD patients

Among different variables age, marital status, educational status, employment status, residence, average annual income (according to quartile income classification), living condition, social support, physical activity, current cigarette use, diagnosis type of CVD illness, age onset of CVD, B-blocker medication, duration of treatment for CVD and lipid profile level—total cholesterol were showed association with depression at P-value < .25 on bivariate analysis (Tables 4, 5 and 6).
Table 5

Socio-demographic factors that associated with depression in bivariate analysis (< .25) among CVD patients in Jimma University Teaching Hospital cardiac clinic, 2014–2015

Characteristics

Non depressed

N (%)

Depressed

N (%)

COR (95% CI)

P-value

Age

 18–26

17 (12.7)

17 (11.3)

1.077 (.456, 2.541)

.866

 27–35

15 (11.2)

21 (14.0)

1.508 (.644, 3.531)

.344

 36–44

20 (14.9)

13 (8.7)

.700 (.291, 1.686)

.426

 45–53

22 (16.4)

25 (16.7)

1.224 (.559, 2.678)

.613

 54–62

28 (20.9)

26 (17.3)

1

 

 63–71

22 (16.4)

28 (18.7)

1.371 (.633, 2.968)

.424

 ≥ 72

10 (7.5)

20 (13.3)

2.154 (.852, 5.448)

.105a

Marital status

 Single

20 (14.9)

13 (8.7)

.615 (.291, 1.298)

.202a

 Married

105 (78.4)

111 (74.0)

1

 

 Divorced/separate

4 (3.0)

10 (6.7)

2.365 (.720, 7.772)

.156a

 Widowed

5 (3.7)

16 (10.7)

3.027 (1.071, 8.556)

.037a

Educational status

 Illiterate

67 (50.0)

84 (56.0)

1

 

 Able to read and write only

20 (14.9)

36 (24.0)

1.436 (.762, 2.706)

.263

 Primary (1–8)

28 (20.9)

19 (12.7)

.541 (.278, 1.053)

.070a

 Secondary (9–12)

14 (10.4)

7 (4.7)

.399 (.152, 1.044)

.061a

 Tertiary (+12)

5 (3.7)

4 (2.7)

.638 (.165, 2.470)

.515

Employment status

 Unemployed

16 (11.9)

35 (23.3)

2.069 (1.053, 4.067)

.035a

 Employed

12 (9.0)

4 (2.7)

.315 (.097, 1.024)

.055a

 Farmer

70 (52.2)

74 (49.3)

1

 

 Merchant

9 (6.7)

10 (6.7)

1.051 (.403, 2.740)

919

 Retired

7 (5.2)

5 (3.3)

.676 (.205, 2.228)

.52

 Housewife

11 (8.2)

14 (9.3)

1.204 (.512, 2.830)

.67

 Other

9 (6.7)

8 (5.3)

.841 (.307, 2.301)

.736

Residence

 Rural areas

80 (59.7)

103 (68.7)

1

 

 Urban areas

54 (40.3)

47 (31.3)

.676 (.415, 1.101)

.116a

Average annual income

 0–999

33 (24.6)

37 (24.7)

1.393 (.723, 2.684)

.322

 1000–3599

32 (23.9)

37 (24.7)

1.437 (.743, 2.776)

.281

 3600–10,799

28 (20.9)

43 (28.7)

1.908 (.985, 3.694)

.055a

 ≥ 10,800

41 (30.6)

33 (22.0)

1

 

aVariables which shown statistically significant association during the bivariate analysis

Table 6

Psychosocial and behavioral related factors that associated with depression in bivariate analysis (< .25) among CVD patients in Jimma University Teaching Hospital cardiac clinic, 2014–2015

Characteristics

Non depressed

N (%)

Depressed

N (%)

COR (95% CI)

P-value

Living condition

 Alone

6 (4.5)

12 (8.0)

1.779 (.648, 4.886)

.263

 With family

121 (90.3)

136 (90.7)

1

 

 Othera

7 (5.2)

2 (1.3)

.254 (.052, 1.247)

.091b

Oslo 3-items social support scale

 Poor support

38 (28.4)

62 (41.3)

1.909 (1.106, 3.293)

.020b

 Moderate support

62 (46.3)

53 (35.3)

1

 

 Strong support

34 (25.4)

35 (23.3)

1.204 (.662, 2.189)

.542

Physical activity

 Yes

79 (59.0)

66 (44.0)

.547 (.341, .877)

.012b

 No

55 (41.0)

84 (56.0)

1

 

Cigarette current user

 Yes

3 (2.2)

11 (7.3)

3.456 (.943, 12.664)

.061b

 No

131 (97.8)

139 (92.7)

1

 

Living condition othera with relative/friends/homeless

bVariables which shown statistically significant association during the bivariate analysis

Those variables widowed, unemployed, poor social support, physical inactivity was significantly associated with depression in bivariate analysis at P-value < .05 (Tables 5, 6 and 7).
Table 7

Clinical and medication related factors that associated with depression in bivariate analysis (< .25) among CVD patients in Jimma University Teaching Hospital cardiac clinic, 2014–2015

Characteristics

Non depressed

N (%)

Depressed

N (%)

COR (95% CI)

P-value

Diagnosis type of CVD illness

 Hypertensive heart diseases

102 (35.9)

48 (35.8)

1

 

 Ischemic heart disease

75 (26.4)

37 (27.6)

.913 (.503, 1.658)

.765

 Valvular heart disease

35 (12.3)

11 (8.2)

1.939 (.86, 4.371)

.110a

 Rheumatic heart disease

26 (9.2)

14 (10.4)

.762 (.321, 1.807)

.537

 Cardiomyopathy

29 (10.2)

16 (11.9)

.722 (.315, 1.654)

.442

 Other

17 (5.0)

8 (6.0)

1.000 (.357, 2.797)

1.00

Age onset of CVD

 9–19

11 (8.2)

12 (8.0)

.679 (.264, 1.745)

.421

 20–29

17 (12.7)

21 (14.0)

.769 (.347, 1.701)

.516

 30–39

24 (17.9)

19 (12.7)

.493 (229, 1.058)

.070a

 40–49

24 (17.9)

27 (18.0)

.700 (.339, 1.445)

.335

 50–59

30 (22.4)

26 (17.3)

.539 (.266, 1.092)

.086a

 ≥ 60

28 (20.9)

45 (30.0)

1

1

Medication

 B-blocker

72 (53.7)

65 (43.3)

1.519 (.950, 2.426)

.081a

Duration of treatment (year)

 ≤ 1

91 (32.0)

50 (37.3)

1

 

 1–2

51 (18.0)

24 (17.9)

1.372 (.69, 2.729)

.367

 2–3

29 (10.2)

12 (9.0)

1.728 (.741, 4.028)

.206a

 3–4

30 (10.6)

11 (8.2)

2.106 (.901, 4.927)

.086a

 ≥ 5

83 (29.2)

37 (27.6)

1.516 (.834, 2.758)

.173a

Lipid profile level—total cholesterol (mg/dl)

 < 200

7 (63.6)

11 (91.7)

4.488 (.495, 40.69)

.182a

 ≥ 200

4 (36.4)

1 (8.3)

1

 

Diagnosis of CVD other—corpulmonary, acute rheumatic fever, congenital heart disease, pericarditis, CHF due to thyrotoxicosis

aVariables which shown statistically significant association during the bivariate analysis

Factors associated with depression in multiple logistic regression among patients with CVD

Multivariable analysis was done and found that those who were unemployed had about 2 times the odds of developing depression as compared to farmers, adjusted odds ratio (AOR = 2.248, 1.102, 4.583). The odds of developing depression among patients employed were 75% less as compared to farmers (AOR = .252, .073, .869). The odds of developing depression among those who had poor social support was 2 times odd of depression as compared to those with moderate social support (AOR = 2.324, 1.290, 4.187). Similarly, among patients, current cigarette user were 5 times greater odds to develop depression as compared to those who were none current cigarette user (AOR = 4.722, 1.218, 18.311). The odds of developing depression among patients who have a habit of doing physical activity was 53% less as compared to who didn’t do physical activity (AOR = .541, .328, .893) (Table 8).
Table 8

Factors that associated with depression in multiple logistic regression of CVD patients in Jimma University Teaching Hospital cardiac clinic, 2014–2015 (n = 284)

Characteristics

Non depression

N (%)

Depression

N (%)

AOR (95% CI)

P-value

Occupational status

 Unemployed

16 (11.9)

35 (23.3)

2.248 (1.102, 4.583)a

.026

 Employed

12 (9.0)

4 (2.7)

.252 (.073, .869)a

.029

 Farmer

70 (52.2)

74 (49.3)

1

 

 Merchant

9 (6.7)

10 (6.7)

.904 (.326, 2.510)

.847

 Retired

7 (5.2)

5 (3.3)

.723 (.212, 2.472)

.605

 Housewife

11 (8.2)

14 (9.3)

1.417 (.587, 3.419)

.438

 Other

9 (6.7)

8 (5.3)

.635 (.224, 1.805)

.395

Oslo 3-items social support scale

 Poor support

38 (28.4)

62 (41.3)

2.324 (1.290, 4.187)a

.005

 Moderate support

62 (46.3)

53 (35.3)

1

 

 Strong support

34 (25.4)

35 (23.3)

1.336 (.702, 2.545)

.378

Current cigarette user

 Yes

3 (2.2)

11 (7.3)

4.722 (1.218, 18.311)a

.025

 No

131 (97.8)

139 (92.7)

1

 

Physical activity

 Yes

79 (59.0)

66 (44.0)

.541 (.328,.893)a

.016

 No

55 (41.0)

84 (56.0)

1

 

aSignificant level in 95% CI

Discussion

In this study, an attempt was made to assess the prevalence and associated factors of depression. The prevalence of depression was 52.8% which high as compared to a study done in the US (21.5%), Pakistan (37%), and Jamaica (19.9%) [19, 30, 31]. The prevalence of depression was almost similar to the study done in Washington, USA 51.0% [38]. However, it was lower in magnitude than a study done in Nigerian 67.0% [50], in Brazil 67.0% [32] and USA (Utah) (75%) [27].

In our study, the finding of depression was higher than the studies done in Pakistan (37.0% and 47.0%), Netherlands (42%) Iran (41.9%), Canada (35%) and Nigeria (30.0%) [30, 3337]. The difference might be studying population, study setting, the tool used, study design and sociocultural difference. The prevalence of depression was higher among CVD patients. This implies that doctors and other professionals should routinely screen depression among patients with CVD.

In this study CVD related employment status, physical activity, current cigarette user and social support were found the potent variable that statically significant association with depression in the final model.

Our study finding revealed that the likelihood of developing depression among those unemployed was 2 times higher than as compared to farmers (AOR = 2.248, 1.102, 4.583). The possibility of developing depression among patients employed was 75% less likely as compared to farmers (AOR = .252, .073, .869). This study in line with the study done in South Korea and the USA [38, 39]. They are more likely to engage in drinking alcohol, smoking, drug use, suicide intentions, and crime. Additionally, because a majority of people among CVD patients were pre-retirement or retirement age was forced to leave their jobs. These things lead to depression among the unemployed [39]. Meta-analyses and systematic reviews did have shown that unemployed have at least twofold risk of mental illness, particularly depression and anxiety disorders, compared to employed persons [40].

In our finding, the likelihood of developing depression among those who had poor social support was 2 times odd of depression as compared to those with moderate social support (AOR = 2.324, 1.290, 4.187). This finding similar to the study done in Canada, Italy, the USA, Brazil, and Iran [4146]. Low social support levels are important risk factors for the subsequent development or worsening of depression.

In our study finding, among patients who current cigarette user was 5 times more likely to develop depression as compared to those who were none current cigarette user (AOR = 4.722, 1.218, 18.311). This finding similar to the study done in the Netherlands supports that smoking as an independent predictor of depression in CVD patients. Smokers, in turn, have a higher risk of being depressed and a decreased chance of recovery from depression. Both tobacco smoking and depression are associated with cardiac mortality and morbidity [47].

Similarly, the study had done in Australia supports our study finding that reports, smoking as an independent predictor of depression in CVD patients. The mechanisms through which smoking is associated with depression might be biogenetic, psychological and environmental factors. Smoking-induced neurobiological changes that might predispose to depression; the transient alleviation of depressive symptoms and psychotropic side effects with smoking [48]. The study was done in Greece and systematic review done also reported that smokers have higher rates of depressive symptoms than nonsmokers [49, 50]. Smoking cessation among depressed CVD patients is associated with concurrent improvement in depression [51]. Our study finding also contrasts with the study done in Toronto, Canada [52].

In our study participants, those who physically active (do moderate to vigorous activity for 30 min or more, at least 4 days in a week) were 46% less likely to develop depression as compared to physically inactivate, (AOR = .541, .328, .893). This is consistent with the study done in Italy and Spain that report that physical inactivity increases the risk of depression [53, 54]. The study was done in Pakistan also supports our study finding, additionally reported that physical activity shows positive effects to reduce the level of depression among CVD patients [55]. Other studies which were done in Canada and the USA also in line with our study finding [56]. Lastly, in this study respondent’s age, sex, place of residence, B-blocker medication, marital status, comorbid diabetes mellitus and hypertension, living condition and lipid profile were not significantly associated with depression among CVD patients in the final model. The finding was in line with the study done in USA, Netherland, Japan, Denmark, Brazil, Pakistan [12, 20, 27, 30, 32, 38, 53, 5759].

Conclusions

Our study finding showed that the prevalence of depression was 52.8% and it was found to be highly prevalent psychiatric comorbidity in adult CVD patients. Depression had independently associated with employment status, physical activity, current cigarette user and social support. This study could be taken as an eye-opener with regards to bridging the knowledge gap that exists in the country and particularly among Jimma University Teaching Hospital’s health workers and specialists working with cardiac patients attending cardiac clinic and could help to put an effort for integration of knowledge from both Internists and psychiatrists through multidisciplinary team approach for achieving quality of patient care.

Abbreviations

ACS: 

acute coronary syndrome

AMI: 

acute myocardial infarction

AF: 

atrial fiberaltion

BDI: 

Beck depression inventory

BMI: 

body mass index

BSC: 

Bachelor of science

CAD: 

coronary arterial disease

CABG: 

coronary artery bypass graft

CHD: 

coronary heart disease

CHF: 

congestive heart disease

CVD: 

cardiovascular disease

CPMJU: 

College of Public Health Medical Science of Jimma University

DIS: 

diagnostic interview schedule

DSM-IV: 

Diagnostic and Statistical Manual of Mental Health Disorders, Fourth Edition

HADS: 

Hospital anxiety and depression scale

HHD: 

hypertension heart disease

HRQOL: 

heart-related quality of life

HTN: 

hypertension

ICD: 

implantable cardioverter-defibrillator

IHD: 

ischemic heart disease

JUST: 

Jimma University Specialized Hospital

JUTH: 

Jimma University Teaching Hospital

LVEF: 

left ventricular ejection fraction

MDD: 

major depressive disorder

MI: 

myocardial infarction

NYHA: 

New York Heart Association

NCDs: 

non-communicable diseases

PHQ-9: 

patient health questioner

QOL: 

quality of life

RHD: 

rheumatic heart disease

SHHD: 

Sudan household survey

SPSS: 

statistical package for social sciences

USA: 

United States of America

WHO: 

World health organization

YLL: 

years of life lost

Declarations

Authors’ contributions

HU, MB, and AB contributed to the design, conduct analysis of the research and in the manuscript preparation. AN contributed to the design, conduct, and analysis of the research. All authors read and approved the final manuscript.

Acknowledgements

We would like to express our gratitude and sincere thanks to the Department of Psychiatry, College of Public Health and Medical Sciences of Jimma University for arranging this opportunity to carry out this research thesis. And also, our sincere and deepest thanks go to the Jimma University Teaching Hospital administration office to allow us to conduct this study. At last, our gratitude to study participants for their unlimited and valuable information and participated in this study.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

We all authors approve that our consent for publication our manuscript titled as prevalence and associated factors of depressive disorders among adult patients with cardiovascular disease at the outpatient cardiac clinic in Jimma University Teaching Hospital, southwest Ethiopia in the international journal of a mental health system. And we put our agreement signature as below.

Data availability

The authors approve that all data underlying the findings are completely accessible without limitation and also pertinent data are in the paper.

Funding

This is from a developing country; our salary couldn’t cover the fee for publication. This paper is original and has a great impact on to design prevention strategy for policymaker and it will be used as the reference for researchers. Therefore, I request your journal to publish this paper free.

Informed consent

Procedures followed were in accordance with the ethical standards of the responsible committee from the Ethical Review Board of Jimma University, College of public health and Medical Sciences. Oral consent was obtained from the study participants. Patient those found to be severally depressed and suicidal risk appropriate intervention was done according to PHQ-9 score.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Research and Training Department of Amanuel Mental Specialized Hospital, Addis Abeba, Ethiopia
(2)
Department of Psychiatry, College of Public Health and Medical Sciences, Jimma University, Jimma, Ethiopia
(3)
Department of Psychiatry, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia

References

  1. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging. 2012.Google Scholar
  2. Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, et al. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry. 2011;68(1):90–100.PubMedPubMed CentralGoogle Scholar
  3. Funk M. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. 2016.Google Scholar
  4. Gelaye B, Lemma S, Deyassa N, Bahretibeb Y, Tesfaye M, Berhane Y, et al. Prevalence and correlates of mental distress among working adults in Ethiopia. Clin Pract Epidemiol Ment Health CP EMH. 2012;8:126.PubMedGoogle Scholar
  5. World Health Organization. Depression: a global crisis. World Mental Health Day, vol. 391. Geneva: World Health Organization; 2012.Google Scholar
  6. Fuster V, Kelly BB. Committee on preventing the global epidemic of cardiovascular disease: meeting the challenges in developing countries board on global health. Kelly, editors. 2010.Google Scholar
  7. Joseph P, Leong D, McKee M, Anand SS, Schwalm J-D, Teo K, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677–94.PubMedGoogle Scholar
  8. Elderon L, Whooley MA. Depression and cardiovascular disease. Prog Cardiovasc Dis. 2013;55(6):511–23.PubMedGoogle Scholar
  9. Khawaja IS, Westermeyer JJ, Gajwani P, Feinstein RE. Depression and coronary artery disease: the association, mechanisms, and therapeutic implications. Psychiatry. 2009;6(1):38.PubMedGoogle Scholar
  10. Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013. https://doi.org/10.1155/2013/695925.PubMedPubMed CentralGoogle Scholar
  11. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Depression and outcome after coronary artery bypass surgery. Lancet. 2002;359(9317):1618.Google Scholar
  12. Gottlieb SS, Khatta M, Friedmann E, Einbinder L, Katzen S, Baker B, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004;43(9):1542–9.PubMedGoogle Scholar
  13. Kronish IM, Krupka DJ, Davidson KW. How should we treat depression in patients with cardiovascular disease? Dialogues Cardiovasc Med DCM. 2012;17(2):126.Google Scholar
  14. Mallik S, Spertus JA, Reid KJ, Krumholz HM, Rumsfeld JS, Weintraub WS, et al. Depressive symptoms after acute myocardial infarction: evidence for highest rates in younger women. Arch Intern Med. 2006;166(8):876–83.PubMedGoogle Scholar
  15. Strik JJ, Lousberg R, Cheriex EC, Honig A. One year cumulative incidence of depression following myocardial infarction and impact on the cardiac outcome. J Psychosom Res. 2004;56(1):59–66.PubMedGoogle Scholar
  16. Lespérance F, Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J Psychosom Res. 2000;48(4–5):379–91.PubMedGoogle Scholar
  17. Suliman A. The state of heart disease in Sudan. Cardiovasc J Afr. 2011;22(4):191.PubMedPubMed CentralGoogle Scholar
  18. Tully PJ, Bennetts JS, Baker RA, McGavigan AD, Turnbull DA, Winefield HR. Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery. Heart Lung J Acute Crit Care. 2011;40(1):4–11.Google Scholar
  19. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527–37.PubMedGoogle Scholar
  20. Maharaj R, Reid S, Misir A, Simeon D. Depression and its associated factors among patients attending chronic disease clinics in southwest Trinidad. West Indian Med J. 2005;54(6):369–74.PubMedGoogle Scholar
  21. Gafarov VV, Panov DO, Gromova EA, Gagulin IV, Gafarova AV. The influence of depression on risk development of acute cardiovascular diseases in the female population aged 25–64 in Russia. Int J Circumpolar Health. 2013;72(1):21223.Google Scholar
  22. Saran R, Puri A, Agarwal M. Depression, and the heart. Indian Heart J. 2012;64(4):397–401.PubMedPubMed CentralGoogle Scholar
  23. Khan FM, Kulaksizoglu B, Cilingiroglu M. Depression, and coronary heart disease. Curr Atheroscler Rep. 2010;12(2):105–9.PubMedGoogle Scholar
  24. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation. 2013. https://doi.org/10.1161/01.cir.0000441139.02102.80.PubMedPubMed CentralGoogle Scholar
  25. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002;53(4):897–902.PubMedPubMed CentralGoogle Scholar
  26. Huntington EB. Memories of Lakeside Camp. 1937.Google Scholar
  27. Geddes MS. Depression detection in Hospitalized cardiac patients. 2010.Google Scholar
  28. Fadare J, Lawal M, Elegbede A, Joseph D, Ampitan B, Ayodele M. Medication adherence and patients satisfaction among psychiatric outpatients in a rural Nigerian Tertiary Healthcare Facility. J Psychiatry. 2014;17:125. https://doi.org/10.4172/Psychiatry.1000125:2.Google Scholar
  29. Abiola T, Udofia O, Zakari M. Psychometric properties of the 3-item Oslo social support scale among clinical students of Bayero University Kano, Nigeria. Malays J Psychiatry. 2013;22(2):32–41.Google Scholar
  30. Bokhari S, Samad A, Hanif S, Hadique S, Cheema M, Fazal M, et al. Prevalence of depression in patients with coronary artery disease in a tertiary care hospital in Pakistan. JPMA J Pak Med Assoc. 2002;52(9):436–9.PubMedGoogle Scholar
  31. Martin J, Neita S, Gibson R. Depression among cardiovascular disease patients on a consultation-liaison service at a general hospital in Jamaica. West Indian Med J. 2012;61(5):499–503.PubMedGoogle Scholar
  32. Pena FM, da Silva Soares J, Paiva BTC, Piracicaba MCT, Marins RM, Barcellos AF, et al. Sociodemographic factors and depressive symptoms in hospitalized patients with heart failure. Exp Clin Cardiol. 2010;15(2):e29.PubMedPubMed CentralGoogle Scholar
  33. Dogar IA, Khawaja IS, Azeem MW, Awan H, Ayub A, Iqbal J, et al. Prevalence and risk factors for depression and anxiety in hospitalized cardiac patients in Pakistan. Psychiatry. 2008;5(2):38.PubMedGoogle Scholar
  34. Jaarsma T, Lesman-Leegte I, Hillege HL, Veeger NJ, Sanderman R, van Veldhuisen DJ, et al. Depression and the usefulness of a disease management program in heart failure: insights from the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) study. J Am Coll Cardiol. 2010;55(17):1837–43.PubMedGoogle Scholar
  35. Bayani B, Yousefi S, Bayani M, Shirmohammadi M, Alimoradi A, Falsoleiman H, et al. Depression and anxiety in a cardiovascular outpatient clinic: a descriptive study. Iran J Psychiatry. 2011;6(3):125.PubMedPubMed CentralGoogle Scholar
  36. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, et al. Depression and prognosis following hospital admission because of acute myocardial infarction. Can Med Assoc J. 2003;168(5):547–52.Google Scholar
  37. Mbakwem AC, Aina OF. Comparative study of depression in hospitalized and stable heart failure patients in an urban Nigerian teaching hospital. Gen Hosp Psychiatry. 2008;30(5):435–40.PubMedGoogle Scholar
  38. Freedland KE, Rich MW, Skala JA, Carney RM, Dávila-Román VG, Jaffe AS. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003;65(1):119–28.PubMedGoogle Scholar
  39. Song EK, Lennie TA, Moser DK. Depressive symptoms increase the risk of rehospitalization in heart failure patients with preserved systolic function. J Clin Nurs. 2009;18(13):1871–7.PubMedPubMed CentralGoogle Scholar
  40. Herbig B, Dragano N, Angerer P. Health in the long-term unemployed. Deutsches Ärzteblatt Int. 2013;110(23–24):413.Google Scholar
  41. Frasure-Smith N, Lesperance F. Coronary artery disease, depression and social support only the beginning. Oxford: Oxford University Press; 2000.Google Scholar
  42. Frasure-Smith N, Lespérance F, Gravel G, Masson A, Juneau M, Talajic M, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101(16):1919–24.PubMedGoogle Scholar
  43. Compare A, Zarbo C, Manzoni GM, Castelnuovo G, Baldassari E, Bonardi A, et al. Social support, depression, and heart disease: a ten year literature review. Front Psychol. 2013;4:384.PubMedPubMed CentralGoogle Scholar
  44. Rollman BL, Belnap BH, LeMenager MS, Mazumdar S, Houck PR, Counihan PJ, et al. Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA. 2009;302(19):2095–103.PubMedPubMed CentralGoogle Scholar
  45. Lino VT, Portela MC, Camacho LA, Atie S, Lima MJ. Assessment of social support and its association to depression, self-perceived health and chronic diseases in elderly individuals residing in an area of poverty and social vulnerability in Rio de Janeiro City, Brazil. PLoS ONE. 2013;8(8):e71712.PubMedPubMed CentralGoogle Scholar
  46. Khayyam-Nekouei Z, Neshatdoost H, Yousefy A, Sadeghi M, Manshaee G. Psychological factors and coronary heart disease. ARYA Atheroscler. 2013;9(1):102.PubMedPubMed CentralGoogle Scholar
  47. de Jonge P, Bos EH. Tobacco smoking and depression: time to move on to a new research paradigm in medicine? BMC Med. 2013;11(1):138.PubMedPubMed CentralGoogle Scholar
  48. Stafford L, Berk M, Jackson HJ. Tobacco smoking predicts depression and poorer quality of life in heart disease. BMC Cardiovasc Disord. 2013;13(1):35.PubMedPubMed CentralGoogle Scholar
  49. Doyle F, Rohde D, Rutkowska A, Morgan K, Cousins G, McGee H. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990 to 2013. Psychosom Med. 2014;76(1):44–57.PubMedGoogle Scholar
  50. Lembke A, Johnson K, DeBattista C. Depression and smoking cessation: does the evidence support psychiatric practice? Neuropsychiatr Dis Treat. 2007;3(4):487.PubMedPubMed CentralGoogle Scholar
  51. Busch AM, Borrelli B, Leventhal AM. The relationship between smoking and depression post-acute coronary syndrome. Curr Cardiovasc Risk Rep. 2011;5(6):510.Google Scholar
  52. Gravely-Witte S, Stewart DE, Suskin N, Grace SL. The association among depressive symptoms, smoking status and antidepressant use in cardiac outpatients. J Behav Med. 2009;32(5):478.PubMedPubMed CentralGoogle Scholar
  53. Larsen KK, Christensen B, Søndergaard J, Vestergaard M. Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions. PLoS ONE. 2013;8(9):e74393.PubMedPubMed CentralGoogle Scholar
  54. Guallar-Castillón P, del Mar Magariños-Losada M, Montoto-Otero C, Tabuenca AI, Rodríguez-Pascual C, Olcoz-Chiva M, et al. Prevalence of depression and associated medical and psychosocial factors in elderly hospitalized patients with heart failure in Spain. Rev Esp Cardiol. 2006;59(8):770–8 (English Edition).PubMedGoogle Scholar
  55. Abidi STJ. Is Physical activity and effective tool to reduce depression after coronary artery event?—a systematic review. 2013.Google Scholar
  56. Mammen G, Faulkner G. Physical activity and the prevention of depression: a systematic review of prospective studies. Am J Prev Med. 2013;45(5):649–57.PubMedGoogle Scholar
  57. May HT, Horne BD, Carlquist JF, Sheng X, Joy E, Catinella AP. Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol. 2009;53(16):1440–7.PubMedGoogle Scholar
  58. van Melle JP, Verbeek DE, van den Berg MP, Ormel J, van der Linde MR, de Jonge P. Beta-blockers and depression after myocardial infarction: a multicenter prospective study. J Am Coll Cardiol. 2006;48(11):2209–14.PubMedGoogle Scholar
  59. Kato N, Kinugawa K, Shiga T, Hatano M, Takeda N, Imai Y, et al. Depressive symptoms are common and associated with adverse clinical outcomes in heart failure with reduced and preserved ejection fraction. J Cardiol. 2012;60(1):23–30.PubMedGoogle Scholar

Copyright

© The Author(s) 2019

Advertisement